Gregory C. Critchfield, President Myriad Genetic Labs at MYRIAD GENETICS INC (MYGN), sold 20,000 shares at $84.50 ($1.7M) on 2009-02-03, disclosed to the SEC on 2009-02-05.
Scheduled sale ($1.7M) by President Myriad Genetic Labs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MYGN | SELL | 2008-09-17 | $2.1M | — | Filing → |
| MYGN | SELL | 2007-09-27 | $1.4M | — | Filing → |
| MYGN | SELL | 2006-04-17 | $873K | — | Filing → |